Cargando…
Allergen-specific immunotherapy with Alutard SQ improves allergic inflammation in house-dust mites-induced allergic asthma rats through inactivation of the HMGB1/TLR4/NF-κB pathway
BACKGROUND: Allergen-specific immunotherapy (AIT) is the only available safe, effective, and long-term treatment for allergic airway diseases, including allergic asthma. However, the potential molecular mechanism of AIT in ameliorating airway inflammation remains unknown. METHODS: Rats were sensitiz...
Autores principales: | Zhai, Yingying, Zheng, Peiyan, Sun, Baoqing, Li, Jing, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922602/ https://www.ncbi.nlm.nih.gov/pubmed/36794148 http://dx.doi.org/10.21037/jtd-22-715 |
Ejemplares similares
-
β-Glucan exacerbates allergic airway responses to house dust mite allergen
por: Hadebe, Sabelo, et al.
Publicado: (2016) -
Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
por: HUI, YU, et al.
Publicado: (2014) -
Cost-effectiveness of SQ(®) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany
por: Green, William, et al.
Publicado: (2017) -
Role of proteinase-activated receptor-2 in allergic sensitization to house dust mite allergens
por: Davidson, Courtney, et al.
Publicado: (2011) -
Immunoglobulin E to allergen components of house dust mite in Korean children with allergic disease
por: Kim, Hwan Soo, et al.
Publicado: (2015)